Eye News and Research

Latest Eye News and Research

Study reveals recommended levels of long-term blood sugar to avoid diabetes-related damage

The levels of long-term blood sugar, HbA1c, can be used to accurately determine the risk of a person with type 1 diabetes developing eye- and kidney complications.

12 Sep 2022

Neuroscientists reveal precise connections between retinal nerve cells and the midbrain structure

For the first time, neuroscientists from Charité – Universitätsmedizin Berlin and the Max Planck Institute for Biological Intelligence (currently in the process of being established) have revealed the precise connections between sensory neurons inside the retina and the superior colliculus, a structure in the midbrain.

12 Sep 2022

Research could lead to a new therapeutic option for patients with bladder cancer

Mount Sinai researchers have made two important discoveries about the mechanism by which bladder cancer cells foil attacks from the immune system.

12 Sep 2022

Study reveals two distinct types of obesity with physiological and molecular differences

A team led by Van Andel Institute scientists has identified two distinct types of obesity with physiological and molecular differences that may have lifelong consequences for health, disease and response to medication.

12 Sep 2022

Long COVID linked to persistence of SARS-CoV-2 spike protein in blood

A new study reports SARS-CoV-2 spike antigen and cytokine levels in a sample of infected individuals, of which a subset had long COVID.

11 Sep 2022

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

A Phase 3 clinical trial evaluating the antiviral tecovirimat, also known as TPOXX, is now enrolling adults and children with monkeypox infection in the United States.

9 Sep 2022

NIH funds $3.35 million to enhance diversity in genomics training

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, will fund $3.35 million over five years to launch the Genome Research Experiences to Attract Talented Undergraduates into the Genomics Field to Enhance Diversity (GREAT) program.

9 Sep 2022

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

A team of Mount Sinai researchers has produced a high-resolution crystal structure of an enzyme essential to the survival of SARS-CoV-2, the virus that causes COVID-19.

9 Sep 2022

New gene therapy approach could help prevent blindness in children with Leber congenital amaurosis

Researchers from the National Eye Institute have developed a gene therapy that rescues cilia defects in retinal cells affected by a type of Leber congenital amaurosis (LCA), a disease that causes blindness in early childhood.

8 Sep 2022

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

A clinical trial evaluating alternative strategies for administering the JYNNEOS monkeypox vaccine to increase the number of available doses has begun enrolling adult volunteers.

8 Sep 2022

Techniques used for SARS-CoV-2 detection in body fluids

In a recent review published in the journal Trends in Analytical Chemistry, researchers provided a comprehensive overview of the current techniques used for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection in bodily fluids.

7 Sep 2022

Study helps reveal the molecular secrets of macular degeneration

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.

7 Sep 2022

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Results of a small, but unique research study, led by researchers from the Seaver Autism Center for Research and Treatment at Mount Sinai and published online in Human Genetics and Genomic Advances, suggest that low-dose ketamine is generally safe, well-tolerated and effective to treat clinical symptoms in children diagnosed with ADNP syndrome (also known as Helsmoortel-VanDerAa syndrome), a rare neurodevelopmental disorder caused by mutations in the activity dependent neuroprotective protein (ADNP) gene.

6 Sep 2022

Exposure to blue light may accelerate aging

A new study provides insights into the novel mechanisms through which blue light exposure interferes with non-retinal cell metabolic pathways in flies.

5 Sep 2022

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

Mount Sinai researchers have published results that show encouraging therapeutic options for patients with the blood cancer multiple myeloma after first-line treatment with bispecific antibodies fails.

1 Sep 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

Brain activity patterns during sleep shed light on the neurobiology behind 22q11.2 Deletion Syndrome

The brain activity patterns during sleep shed light on the neurobiology behind a genetic condition called 22q11.2 Deletion Syndrome (22q11.2DS) and could be used as a biomarker to detect the onset of neuropsychiatric disorders in people with 22q11.2DS.

30 Aug 2022

The first dose response for SARS-CoV-2 solution exposed to UV222

Researchers used culture and molecular assays to provide the first dose-response for SARS-CoV-2 solution exposed to UV222.

30 Aug 2022

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

The earlier individuals develop Type 2 diabetes or hypertension in life, the earlier they are likely to develop primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, researchers from UT Southwestern reported in a recent study.

29 Aug 2022

Music intervention can help bridge the gap between dementia patients and their loved ones

People with dementia often lose their ability to communicate verbally with loved ones in later stages of the disease.

29 Aug 2022

Eye News and Research

Latest Eye News and Research

Study reveals recommended levels of long-term blood sugar to avoid diabetes-related damage

Neuroscientists reveal precise connections between retinal nerve cells and the midbrain structure

Research could lead to a new therapeutic option for patients with bladder cancer

Study reveals two distinct types of obesity with physiological and molecular differences

Long COVID linked to persistence of SARS-CoV-2 spike protein in blood

Phase 3 clinical trial commences to evaluate antiviral for monkeypox

NIH funds $3.35 million to enhance diversity in genomics training

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

New gene therapy approach could help prevent blindness in children with Leber congenital amaurosis

Clinical trial begins evaluating alternative strategies to administer the JYNNEOS monkeypox vaccine

Techniques used for SARS-CoV-2 detection in body fluids

Study helps reveal the molecular secrets of macular degeneration

Low-dose ketamine is safe and effective to treat children with ADNP syndrome, study suggests

Exposure to blue light may accelerate aging

Study shows encouraging therapeutic options for patients with relapsed multiple myeloma

The currently available evidence on viral-induced parkinsonism

Brain activity patterns during sleep shed light on the neurobiology behind 22q11.2 Deletion Syndrome

The first dose response for SARS-CoV-2 solution exposed to UV222

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

Music intervention can help bridge the gap between dementia patients and their loved ones

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Eye News and Research

Latest Eye News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in